Port
Abbott Laboratories (ABT) Earnings
Upcoming earnings report dates, analyst consensus, and how Abbott Laboratories' share price reacted to past earnings — all in one place, in English.
When Does Abbott Laboratories Report Earnings?
The next Abbott Laboratories report is due on October 21, 2026. The date is based on the company's announcement.
The expected earnings per share (EPS) is 1.42 USD. Analyst forecasts range from 1.31 to 1.44 USD. The market reacts not to the absolute earnings, but to the difference between the actual result and this forecast.
Expected revenue: 12.99 B USD.
Abbott Laboratories' Last Report: What the Numbers Showed
Abbott Laboratories' last published report covers the quarter ended June 30, 2026. EPS reached 1.31 USD compared to analysts' forecast of 1.28 USD — 2.61% above expectations. On the first trading day after the release, the share price changed by +12.78%.
Insider Transactions: Abbott Laboratories
Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.
How the stock reacted to past earnings
The company beat analyst estimates in 100% of the last 4 quarters.
The average share price change on the day after earnings release is 8.18% — regardless of direction. The largest move was 12.78%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.
| Quarter | Release date | EPS estimate | Actual EPS | Surprise | Share price reaction |
|---|---|---|---|---|---|
| June 30, 2026 | July 16, 2026 | 1.28 | 1.31 | +2.61% | +12.78% |
| March 31, 2026 | April 16, 2026 | 1.15 | 1.15 | +0.33% | -4.68% |
| December 31, 2025 | January 22, 2026 | 1.49 | 1.50 | +0.34% | -11.02% |
| September 30, 2025 | October 15, 2025 | 1.30 | 1.30 | +0.05% | -4.23% |
How much this company's stock moves after earnings
Abbott Laboratories' share price changes by an average of 8.18% on the first trading session after earnings release — calculated from the last 4 reports, regardless of direction. This ranks 45 out of 180 companies for which we calculated this statistic.
Analyst forecasts for upcoming periods
The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.
| Period | EPS estimate | EPS a year ago | Change | Revenue forecast | Analysts |
|---|---|---|---|---|---|
| Current quarter | 1.42 | 1.30 | +8.86% | $12.99 bn | 23 |
| Next quarter | 1.63 | 1.50 | +8.99% | $13.54 bn | 22 |
| Current year | 5.52 | 5.15 | +7.12% | $50.20 bn | 27 |
| Next year | 6.07 | 5.52 | +9.94% | $54.53 bn | 27 |
Revenue and margins quarter by quarter
Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.
| Quarter | Revenue | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|
| March 31, 2026 | $11.16 bn | 56.20% | 12.05% | 9.65% |
| December 31, 2025 | $11.46 bn | 57.05% | 19.64% | 15.50% |
| September 30, 2025 | $11.37 bn | 55.36% | 18.09% | 14.46% |
| June 30, 2025 | $11.14 bn | 56.44% | 18.42% | 15.97% |
| March 31, 2025 | $10.36 bn | 56.86% | 16.34% | 12.79% |
Abbott Laboratories Dividend
The next ex-dividend date for Abbott Laboratories is October 15, 2026. To receive this payment, shares must be held by the end of the session preceding this date — purchasing on the ex-dividend date itself is too late.
Who Reports in the Coming Weeks
Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.
About Abbott Laboratories
Abbott Laboratories is listed on the New York Stock Exchange under the ticker ABT, and its headquarters are located in the United States. The company belongs to the Healthcare sector (industry: Medical Devices).
- Ticker: ABT
- Exchange: New York Stock Exchange
- Trading Currency: USD
- Sector: healthcare
- Number of Analysts Providing Estimates: 26
- 52-Week Range: 81.97 – 133.34
- Company website: https://www.abbott.com
Frequently Asked Questions
When Does Abbott Laboratories Report Earnings?
The next report is scheduled for October 21, 2026.
What Were Abbott Laboratories' Results Last Quarter?
For the quarter ended June 30, 2026: earnings per share $1.31. This is +2.61% compared to analyst forecasts.
What is Abbott Laboratories' Stock Ticker?
ABT — on the New York Stock Exchange. You may also see it listed as ABT on quote services.
What is the EPS Forecast for Abbott Laboratories?
The analyst consensus for the upcoming quarter is $1.42 per share. Individual forecasts range from $1.31 to $1.44.
How Much Does Abbott Laboratories' Share Price Usually Change After Earnings?
On average, 8.18% in the session after publication, counting both directions. The largest recorded movement was 12.78%.
Does Abbott Laboratories usually beat analysts' estimates?
In the last 4 quarters, results exceeded forecasts in 100% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.
Where can I find Abbott Laboratories' earnings in English?
On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.
Other companies in the healthcare sector
A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.
Related
Track Abbott Laboratories on Portevo
The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.
Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.
Your entire portfolio, company earnings, and insider trades in one place
Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.
- Portfolio with Net Profit After Costs
- Earnings Calendar for Your Companies
- Pelosi, Trump, and CEO Trades on a Chart
- Works in Browser and on iPhone
No credit card required. A demo portfolio is available immediately; create your own by uploading a report.
